18F-FDG-PET
assisted analysis
autoimmune encephalitis
limbic encephalitis
voxel-based analysis
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
29 May 2020
29 May 2020
Historique:
received:
17
04
2020
revised:
26
05
2020
accepted:
27
05
2020
entrez:
4
6
2020
pubmed:
4
6
2020
medline:
4
6
2020
Statut:
epublish
Résumé
Brain positron emission tomography imaging with 18Fluorine-fluorodeoxyglucose (FDG-PET) has demonstrated utility in suspected autoimmune encephalitis. Visual and/or assisted image reading is not well established to evaluate hypometabolism/hypermetabolism. We retrospectively evaluated patients with autoimmune encephalitis between 2003 and 2018. Patients underwent EEG, brain magnetic resonance imaging (MRI), cerebrospinal fluid (CSF) sampling and autoantibodies testing. Individual FDG-PET images were evaluated by standard visual reading and assisted by voxel-based analyses, compared to a normal database. For the latter, three different methods were performed: two based on statistical surface projections (Siemens syngo.via Database Comparison, and 3D-SSP Neurostat) and one based on statistical parametric mapping (SPM12). Hypometabolic and hypermetabolic findings were grouped to identify specific patterns. We found six cases with definite diagnosis of autoimmune encephalitis. Two cases had anti-LGI1, one had anti-NMDA-R and two anti-CASPR2 antibodies, and one was seronegative.
Identifiants
pubmed: 32486044
pii: diagnostics10060356
doi: 10.3390/diagnostics10060356
pmc: PMC7344773
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Lancet Neurol. 2013 Feb;12(2):157-65
pubmed: 23290630
BMC Neurol. 2014 Jun 20;14:136
pubmed: 24950993
Neurology. 2020 Jan 14;94(2):e217-e224
pubmed: 31882532
BMC Neurol. 2013 May 31;13:55
pubmed: 23725534
AJR Am J Roentgenol. 1998 Jun;170(6):1659-60
pubmed: 9609193
Phys Med. 2015 Dec;31(8):948-955
pubmed: 26249138
J Neuroimmunol. 2016 Aug 15;297:156-8
pubmed: 27397089
Seizure. 2011 Apr;20(3):266-70
pubmed: 21146427
J Nucl Med. 1995 Jul;36(7):1238-48
pubmed: 7790950
J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):681-6
pubmed: 22566598
Lancet Neurol. 2016 Sep;15(10):1009-10
pubmed: 27571149
Eur J Nucl Med Mol Imaging. 2015 Sep;42(10):1522-9
pubmed: 26041084
Nurs Stand. 1989 May 20;3(34):42
pubmed: 27237517
Nucl Med Commun. 2014 Oct;35(10):1038-46
pubmed: 25023997
Neurol Neuroimmunol Neuroinflamm. 2017 May 11;4(4):e352
pubmed: 28567435
Brain. 2012 May;135(Pt 5):1622-38
pubmed: 22539258
Clin Nucl Med. 2012 Sep;37(9):e213-8
pubmed: 22889795
Clin Imaging. 2015 Mar-Apr;39(2):329-33
pubmed: 25487436
Q J Nucl Med Mol Imaging. 2014 Dec;58(4):332-43
pubmed: 25391316
Autoimmune Dis. 2016;2016:9450452
pubmed: 27559482
Clin Nucl Med. 2004 Oct;29(10):620-5
pubmed: 15365433
Neurology. 2012 Aug 14;79(7):720-1
pubmed: 22891114
J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):235-6
pubmed: 20667855
J Nucl Med. 2017 Aug;58(8):1307-1313
pubmed: 28209905
Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):353-357
pubmed: 27924371
Lancet Neurol. 2016 Apr;15(4):391-404
pubmed: 26906964
J Neurosci. 2010 Apr 28;30(17):5866-75
pubmed: 20427647
J Clin Neurosci. 2008 Sep;15(9):961-71
pubmed: 18411052
Clin Case Rep. 2019 Aug 08;7(9):1750-1753
pubmed: 31534741
Brain. 2005 Aug;128(Pt 8):1764-77
pubmed: 15888538
Epileptic Disord. 2012 Mar;14(1):90-3
pubmed: 22426441